Uncategorized
ViiV Healthcare Submits Regulatory Application to European Medicines Agency for Investigational Cabotegravir to Be Used in Combination With Rilpivirine as the First Monthly, Injectable Treatment for HIV
LONDON--(BUSINESS WIRE)--ViiV HC submits application to EMA for investigational cabotegravir used with rilpivirine as the first monthly, injectable treatment for HIV